Search all trials

Find therapies in clinical trials near you – page 27

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Psoriasis

Not recruiting

InvestigationalNo placebo

Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Risankizumab

Contact Research Centre

B-cell type acute leukaemia

Not recruiting

Registered drugNo placebo

Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Alemtuzumab

Contact Research Centre

Atypical haemolytic uraemic syndrome+1

Not recruiting

Registered drugNo placebo

Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Ravulizumab

Contact Research Centre

Autism spectrum disorder

Not recruiting

Registered drug

Study on the Effects of Pitolisant for Children and Adolescents with Autism Spectrum Disorder

Registered drug

Spain

Participants:0–17 years
Substances:Pitolisant

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Nivolumab

Contact Research Centre

Food allergy

Not recruiting

Registered drug

Study on Long-Term Safety of Ligelizumab for Patients with Food Allergies

Registered drug

Spain

Participants:0–17 years · 18–64 years
Substances:Epinephrine

Contact Research Centre

Psoriasis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

Registered drugNo placebo

Spain

Participants:0–17 years

Contact Research Centre

Juvenile idiopathic arthritis

Not recruiting

InvestigationalNo placebo

Study on the Effects and Safety of Upadacitinib for Children with Polyarticular Juvenile Idiopathic Arthritis

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Upadacitinib

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Olaparib

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Angelman's syndrome

Not recruiting

InvestigationalNo placebo

Study on the Safety and Tolerability of Rugonersen in Patients with Angelman Syndrome

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Rugonersen

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Nemolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 27

329 trials match your criteria

Psoriasis

Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

B-cell type acute leukaemia

Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Atypical haemolytic uraemic syndrome+1

Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

Autism spectrum disorder

Study on the Effects of Pitolisant for Children and Adolescents with Autism Spectrum Disorder

Hodgkin's disease

Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Food allergy

Study on Long-Term Safety of Ligelizumab for Patients with Food Allergies

Psoriasis

Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

Juvenile idiopathic arthritis

Study on the Effects and Safety of Upadacitinib for Children with Polyarticular Juvenile Idiopathic Arthritis

Neoplasm

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Angelman's syndrome

Study on the Safety and Tolerability of Rugonersen in Patients with Angelman Syndrome

Dermatitis atopic

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.